GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » QuidelOrtho Corp (NAS:QDEL) » Definitions » Piotroski F-Score

QuidelOrtho (QuidelOrtho) Piotroski F-Score

: 5 (As of Today)
View and export this data going back to 1992. Start your Free Trial

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

QuidelOrtho has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for QuidelOrtho's Piotroski F-Score or its related term are showing as below:

QDEL' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 5   Max: 7
Current: 5

During the past 13 years, the highest Piotroski F-Score of QuidelOrtho was 7. The lowest was 4. And the median was 5.


QuidelOrtho Piotroski F-Score Historical Data

The historical data trend for QuidelOrtho's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Array ( [0] => - [1] => - [2] => - [3] => - [4] => - [5] => 6.00 [6] => 7.00 [7] => 5.00 [8] => 4.00 [9] => 5.00 )
QuidelOrtho Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 7.00 5.00 4.00 5.00

QuidelOrtho Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Piotroski F-Score Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 3.00 4.00 5.00 5.00

Competitive Comparison

For the Medical Devices subindustry, QuidelOrtho's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QuidelOrtho Piotroski F-Score Distribution

For the Medical Devices & Instruments industry and Healthcare sector, QuidelOrtho's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where QuidelOrtho's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was 48.8 + -53.2 + -12.7 + 7 = $-10 Mil.
Cash Flow from Operations was 188.9 + -30.6 + 41.5 + 80.4 = $280 Mil.
Revenue was 846.1 + 665.1 + 744 + 742.6 = $2,998 Mil.
Gross Profit was 448.6 + 296.4 + 368.1 + 381.3 = $1,494 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was
(8855.8 + 8787.1 + 8550.3 + 8539.1 + 8563.1) / 5 = $8659.08 Mil.
Total Assets at the begining of this year (Dec22) was $8,856 Mil.
Long-Term Debt & Capital Lease Obligation was $2,448 Mil.
Total Current Assets was $1,311 Mil.
Total Current Liabilities was $834 Mil.
Net Income was 479.9 + 19.3 + 19.2 + 30.3 = $549 Mil.

Revenue was 1002.3 + 613.4 + 783.8 + 866.5 = $3,266 Mil.
Gross Profit was 742 + 337.5 + 407.5 + 449 = $1,936 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was
(2430.4 + 3093.125 + 8822.4 + 8655.5 + 8855.8) / 5 = $6371.445 Mil.
Total Assets at the begining of last year (Dec21) was $2,430 Mil.
Long-Term Debt & Capital Lease Obligation was $2,617 Mil.
Total Current Assets was $1,575 Mil.
Total Current Liabilities was $1,007 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

QuidelOrtho's current Net Income (TTM) was -10. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

QuidelOrtho's current Cash Flow from Operations (TTM) was 280. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=-10.1/8855.8
=-0.0011405

ROA (Last Year)=Net Income/Total Assets (Dec21)
=548.7/2430.4
=0.22576531

QuidelOrtho's return on assets of this year was -0.0011405. QuidelOrtho's return on assets of last year was 0.22576531. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

QuidelOrtho's current Net Income (TTM) was -10. QuidelOrtho's current Cash Flow from Operations (TTM) was 280. ==> 280 > -10 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=2447.6/8659.08
=0.28266282

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=2617.2/6371.445
=0.41077024

QuidelOrtho's gearing of this year was 0.28266282. QuidelOrtho's gearing of last year was 0.41077024. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=1310.5/833.8
=1.57171984

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=1575.1/1007
=1.56415094

QuidelOrtho's current ratio of this year was 1.57171984. QuidelOrtho's current ratio of last year was 1.56415094. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

QuidelOrtho's number of shares in issue this year was 66.8. QuidelOrtho's number of shares in issue last year was 67. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=1494.4/2997.8
=0.4984989

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=1936/3266
=0.59277404

QuidelOrtho's gross margin of this year was 0.4984989. QuidelOrtho's gross margin of last year was 0.59277404. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=2997.8/8855.8
=0.33851261

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=3266/2430.4
=1.34381172

QuidelOrtho's asset turnover of this year was 0.33851261. QuidelOrtho's asset turnover of last year was 1.34381172. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+1+0+1+1+1+1+0+0
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

QuidelOrtho has an F-score of 5 indicating the company's financial situation is typical for a stable company.

QuidelOrtho  (NAS:QDEL) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


QuidelOrtho Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of QuidelOrtho's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


QuidelOrtho (QuidelOrtho) Business Description

Traded in Other Exchanges
Address
9975 Summers Ridge Road, San Diego, CA, USA, 92121
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make better decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.
Executives
Louise Brandy officer: SVP, Chief Information Officer 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA 92121
Patrick Klein officer: Chief Administrative Officer 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA 92121
Christopher M Smith director 125 CONSTITUTION DRIVE, MENLO PARK CA 94025
Edward L. Michael director 618 SHERIDAN SQUARE, EVANSTON IL 60202
William J. Ferenczy officer: SVP, Cardio/Metabolic Unit 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Werner Kroll officer: SVP, Research and Development 12544 HIGH BLUFF DRIVE, SUITE 200, SAN DIEGO CA 92130
Kenneth F Buechler director
Robert R. Schmidt director C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004
Tamara A. Ranalli officer: SVP, Molecular Bus. Unit 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Stephen H. Wise director C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004
Robert Joseph Bujarski officer: See Remarks C/O QUIDEL CORPORATION, 12544 HIGH BLUFF DRIVE, SUITE 200, SAN DIEGO CA 92130
Wilkins Joseph D Jr. director 82414 PUCCINI DRIVE, INDIO CA 92203
Michelle A. Hodges officer: SVP, General Counsel 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA 92121
Douglas C Bryant director, officer: Chairman & CEO C/O QUIDEL CORPORATION, 12544 HIGH BLUFF DRIVE, SUITE 200, SAN DIEGO CA 92130
Joseph M Busky officer: Chief Financial Officer 1717 DEERFIELD ROAD, DEERFIELD IL 60015